MedPageToday
MedPage Today) — SAVANNAH, Ga. — Investigational nipocalimab plus standard of care achieved sustained reductions in immunoglobulin G (IgG) and appeared to be safe for adolescent patients with generalized myasthenia gravis (gMG), the phase…
Read More
Sustained Disease Control in Adolescent Myasthenia Gravis With FcRn Blocker
Qiana Wiers
17:25
MedPage Today) — SAVANNAH, Ga. — Investigational nipocalimab plus standard of care achieved sustained reductions in immunoglobulin G (IgG) and appeared to be safe for adolescent patients with generalized myasthenia gravis (gMG), the phase…
